表柔比星法玛新乳腺癌治疗-课件.pptVIP

目录 含法玛新?FEC/CEF方案是NCCN指南和St Gallen共识推荐的早期乳腺癌辅助治疗的基础方案1，2 FEC100相比FEC50显著提高10年无病生存率和总生存率3 FEC100的迟发性心脏毒性和继发性恶性肿瘤发生率与FEC50无显著差异3 1. NCCN Clinical Practice Guidelines in Oncology?；Breast Cancer ；V.2.2007 3. Jacques Bonneterre, Henri Roché, et al. Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial. J Clin Oncol. 2005 Apr 20;23(12):2686-93. 2. A. Goldhirsch et al. Progress and promise: highlights of the international expert consensus